Guide | February 2020 | Download PDF
2020 is set to be a crucial year in the fight for access to safe, effective, affordable and quality assured medicines in Europe and beyond.
Key moments to watch for in the coming year include the evaluation of Paediatric and Orphan medicine designations, progress on reform of Health Technology Assessments (HTA) and the European Union’s (EU) review of intellectual property (IP) as an incentive for innovation.
There will be ample opportunity to scale-up our work on transparency, pharmaceutical promotion and the use of TRIPS flexibilities to stimulate competition and reduce prices . It all adds up to another busy year for Health Action International’s (HAI) European Projects Team.
This guide will take you through our projects for 2020, and some of our highlights from 2019.
Find out more